NCT06695221

Improving Health Outcomes With Kefir

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 156 (estimated)
• Sponsor: University of Alberta · Academic / Other
• Sex: All
• Age: 24 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

The purpose of the study is to ascertain whether traditional kefir not only enhances vascular health but also contributes to improved immune outcomes in both male and female participants at higher risk or living with Type 2 Diabetes (T2D) after 12 weeks of treatment.

Detailed description

Participants who sign the written consent form will undergo a screening process to determine eligibility for study entry. At the baseline visit, recruited participants will be randomized in a double-blind manner (participant and study coordinator) to consume either 350 mL of traditional fermented kefir or 350 mL of a placebo (milk) daily. During the 12 weeks of intervention, health outcomes will be measured and collected for further analysis.

Conditions

• Systemic Inflammatory Response
• Diabetes Mellitus, Type 2
• Cardiovascular Diseases

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Traditional Kefir	350 mL/day of traditional fermented/prepared kefir
DIETARY_SUPPLEMENT	Milk (placebo)	350 mL/day of commercial 2% fat milk

Timeline

• Start date: 2026-03-24
• Primary completion: 2027-12-01
• Completion: 2027-12-01
• First posted: 2024-11-19
• Last updated: 2026-03-12

Locations

1 site across 1 country: Canada